Promoting Pharmaceutical Innovation While Controlling Health Care Costs

×

Health care policies should encourage the rapid development of innovative drugs that improve disease outcomes or cure disease, while avoiding high spending that does not reflect value. This project will describe how current pharmaceutical policies are addressing the challenge of innovation and cost, and will develop a framework for considering alternatives that might lead to higher-value pharmaceutical use and innovation. Ideal policies would provide strong financial incentives to support the development of valuable treatments, but would also prevent high prices that do not reflect value, and prevent utilization of more costly treatments when less costly but similarly effective options are available. Since it is difficult to develop actual policies that meet this ideal, this project will describe tradeoffs and promising directions for pharmaceutical policies that could enhance both valuable innovation and cost control.

Grant Details

Grantee Organization:
Brookings Institution
Principal Investigator:
Mark McClellan, M.D., Ph.D., M.P.A.
Award Amount:
$50,000.00
Approval Date:
May 22, 2015

Forgot Password

An email has been sent to {{email}} with your reset password.

Account was not found. Please go to the login page and enter a new password.

Account was not found. Please try again with a different email address.

There was an error when attempting to send to {{email}}. Please contact an administrator.